Jafron Biomedical Co., Ltd.
Established in 1989, Jafron Biomedical (ChiNext: JFSW) is a global provider of technology, product and therapy service in the hemoadsorption industry. With a market value of $7 billion, Jafron has three branches, 11 subsidiaries, one sub-subsidiary and medical foundation, insurance, etc. Jafron has diligently devoted to the R&D, production and sales of blood purification products primarily in the hemoadsorption field for decades. It is dedicated to providing professional services to patients worldwide, covering ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, etc.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Internationally (various countries)
- Year Founded:
- 1989
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
The company set 183 offices in China and five global service centers, including Vietnam, Europe, South America, etc., with a professional therapy-providing team of over 1,100 staff and 1,000 partners. With more than 20-years of clinical experience, the company's flagship product, 'HA series disposable hemoperfusion cartridge,' originally developed by Jafron, has been adopted in more than 8,000 key hospitals across 80 countries and regions, with 5 million cases of clinical application annually.
As a global adsorption therapies provider, Jafron is involved in all aspects of exploring solutions for disease, from research and development of new hemoperfusion therapies to manufacturing our hemoadsorption products, right through to offering comprehensive therapy options. Jafron will not rest in its effort to explore novel medical fields to save lives, improve patients' quality of life, and realize the vision of 'Health Technology for a better world.'
Main Products
HA series hemoperfusion cartridge, BS bilirubin adsorption column and DNA immunoadsorption column, Hemoperfusion Machine and Blood Purification Machine, etc.
Dong Fan
Chairman of the Board
Dong Fan, currently chairman, president, and chief executive officer of Jafron, is responsible for its strategic direction, overall performance, and long-term growth plan. He is proficient in business management and marketing with excellent commercial awareness, a sense of technological innovation and market development, and a powerful consciousness and ability to combine social resources.
Mr. Dong graduated from the Shanghai University of Finance and Economics with a bachelor's degree in trade and economics in 1992, graduated from Sun Yet-Sen University with a master's degree in business management. Prior to steering Jafron in 1989, Mr. Dong was engaged in marketing and management in Livzon Pharmaceutical Group Co., Ltd.